For healthcare professionals. This information does not replace clinical judgement in the individual case; the current summary of product characteristics and the guidelines cited are authoritative.
Medically reviewed: Dr. med. univ. Daniel Pehböck, DESA, 01.11.2026
Physostigmine (Cholinesterase inhibitor (CNS-penetrant) – antidote for anticholinergic syndrome) – indications: Anticholinergic syndrome due to poisoning – adults, Central anticholinergic syndrome / delayed emergence after surgery, Anticholinergic syndrome – children. Weight-based dosing in mg and ml in the app, with sources.
Indications
- Anticholinergic syndrome due to poisoning – adults
- Central anticholinergic syndrome / delayed emergence after surgery
- Anticholinergic syndrome – children
Complete in the app
Weight-based doses in mg and ml, preparations, contraindications and notes – in the app, also offline.
Used in
Sources and guidelines
- Summaries of product characteristics of authorised products – product and section for each dose in the app.